TL
BIIB icon

TrueWealth LLC’s Biogen BIIB Stock Holding History

TrueWealth LLC’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$17K Hold
63
– – 0.01% 395
2020
Q1 		$20K Hold
63
– – 0.01% 352
2019
Q4 		$19K Hold
63
– – 0.01% 382
2019
Q3 		$15K Sell
63
-4
-6% -$931 0.01% 403
2019
Q2 		$16K Hold
67
– – 0.01% 397
2019
Q1 		$16K Buy
67
+55
+458% +$17.3K 0.01% 388
2018
Q4 		$4K Sell
12
-31
-72% -$9.89K ﹤0.01% 574
2018
Q3 		$15K Hold
43
– – 0.01% 417
2018
Q2 		$12K Buy
43
+15
+54% +$4.22K 0.01% 450
2018
Q1 		$8K Buy
28
+10
+56% +$3.1K ﹤0.01% 487
2017
Q4 		$6K Buy
+18
New +$5.77K ﹤0.01% 599

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

TrueWealth LLC's BIIB Position: Q2 2020 in Review

TrueWealth LLC held its Biogen (BIIB) position steady in Q2 2020 at 63 shares worth $17K. The position accounts for 0.01% of the portfolio, ranked #395.

TrueWealth LLC first reported a position in BIIB in Q4 2017 and has held it in 11 quarters since. The position peaked at $20K in Q1 2020. 1,060 funds tracked by Wall St. Rank hold BIIB as of Q2 2020.

  • TrueWealth LLC held 63 shares of Biogen worth $17K as of Q2 2020.
  • TrueWealth LLC left its Biogen share count unchanged in Q2 2020.
  • Biogen made up 0.01% of TrueWealth LLC's portfolio in Q2 2020, its #395 holding.
  • TrueWealth LLC first reported a position in Biogen in Q4 2017 and has held it in 11 quarters since.
  • TrueWealth LLC's Biogen position peaked at $20K in Q1 2020.
  • 1,060 funds tracked by Wall St. Rank held Biogen as of Q2 2020.

Based on TrueWealth LLC's 13F filing for Q2 2020, filed 15 Jul 2020.